drugset / Trial / NCT00100074
To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1
Diagnostic
Summary
To assess the safety and tolerability of 7.5, 15 and 30 mg of sublingual lobeline.
Timeline
- Start
- 2004-09
- Primary completion
- —
- Completion
- 2005-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lobeline | Small molecule | 7.5 mg | — |
| Subject | Lobeline | Small molecule | 15 mg | — |
| Subject | Lobeline | Small molecule | 30 mg | — |